Role of the oestrogen receptor (ESR1 PvuII and ESR1 325 C→G) and progesterone receptor (PROGINS) polymorphisms in genetic susceptibility to migraine in a North Indian population

Cephalalgia

Volumn 30, Issue 3, 2010, Pages 311-320

  Joshi, G ^a   Pradhan, S ^a,b   Mittal, B ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b INSTITUTE OF HUMAN BEHAVIOUR AND ALLIED SCIENCES   (India)

Author keywords

Genetic susceptibility; Healthy controls; Migraine with aura; Migraine without aura; Oestrogen receptor (ESR1); Progesterone receptor insertion polymorphism (PROGINS); Tension type headache

Indexed keywords

ESTROGEN RECEPTOR ALPHA; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE INSERTION; GENE INTERACTION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE MAP; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TENSION HEADACHE;

ESTROGEN RECEPTOR ALPHA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INDIA; MALE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; POLYMORPHISM, GENETIC; RECEPTORS, PROGESTERONE; TENSION-TYPE HEADACHE;

EID: 77956235127     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2009.01967.x     Document Type: Article

References (27)

1. Silberstein SD, Merriam GR. Physiology of the menstrual cycle. Cephalalgia 2000;20:148-54.
2. Maggioni F, Alessi C, Maggino T, Zanchin G. Headache during pregnancy. Cephalalgia 1997;17:765-69.
3. Somerville BW. The role of progesterone in menstrual migraine. Neurology 1971;21:853-59.
4. Martin VT, Behbehani M. Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis-part I. Headache 2006;46:3-23.
5. Bethea CL, Lu NZ, Gundlah C, Streicher JM. Diverse actions of ovarian steroids in the serotonin neural system. Front Neuroendocrinol 2002;23:41-100.
6. Colson NJ, Lea RA, Quinlan S, MacMillan J, Griffiths LR. The estrogen receptor 1 G594A polymorphism is associated with migraine susceptibility in two independent case/control groups. Neurogenetics 2004;5:129-33.
7. Colson NJ, Lea RA, Quinlan S, MacMillan J, Griffiths LR. Investigation of hormone receptor genes in migraine. Neurogenetics 2005;6:17-23.
8. Iwase H, Greenman JM, Barnes DM, Hodgson S, Bobrow L, Mathew CG. Sequence variants of the estrogen receptor (ER) gene found in breast cancer patients with ER negative and progesterone receptor positive tumors. Cancer Lett 1996;108:179-84.
9. Van Duijnhoven FJ, Bezemer ID, Peeters PH, Roest M, Uitterlinden AG, Grobbee DE, et al. Polymorphisms in the estrogen receptor alpha gene and mammographic density. Cancer Epidemiol Biomarkers Prev 2005;14:2655-60.
10. Schuit SC, de Jong FH, Stolk L, Koek WN, van Meurs JB, Schoofs MW, et al. Estrogen receptor alpha gene polymorphisms are associated with estradiol levels in postmenopausal women. Eur J Endocrinol 2005;153:327-34.
11. Colson NJ, Lea RA, Quinlan S, Griffiths LR. No role for estrogen receptor 1 gene intron 1 Pvu II and exon 4 C325G polymorphisms in migraine susceptibility. BMC Med Genet 2006;28:7-12.
12. Oterino A, Pascual J, Ruiz de Alegría C, Valle N, Castillo J, Bravo Y, et al. Association of migraine and ESR1 G325C polymorphism. Neuroreport 2006;23:61-4.
13. Kaunisto MA, Kallela M, Hämäläinen E, Kilpikari R, Havanka H, Harno H, et al. Testing of variants of the MTHFR and ESR1 genes in 1798 Finnish individuals fails to confirm the association with migraine with aura. Cephalalgia 2006;26:1462-72.
14. Rowe SM, Coughlan SJ, McKenna NJ, Garrett E, Kieback DG, Carney DN, et al. Ovarian carcinoma-associated TaqI restriction fragment length polymorphism in intron G of the progesterone receptor gene is due to an Alu sequence insertion. Cancer Res 1995;55:2743-45.
15. Lipton RB, Cady RK, Stewart WF, Wilks K, Hall C. Diagnostic lessons from the spectrum study. Neurology 2002;58: S2731.
16. HCSIHS. International Classification of Headache Disorders (2nd Edition). Cephalalgia 2004;24(Suppl. 1):1-160.
17. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 1988;16:1215.
18. Lai IC, Liao DL, Bai YM, Lin CC, Yu SC, Chen JY, et al. Association study of the estrogen receptor polymorphisms with tardive dyskinesia in schizophrenia. Neuropsychobiology 2002;46:173-5.
19. Onsory K, Sobti RC, Al-Badran AI, Watanabe M, Shiraishi T, Krishan A, et al. Hormone receptor-related gene polymorphisms and prostate cancer risk in North Indian population. Mol Cell Biochem 2008;314:25-35.
20. Mitra S, Desai M, Khatkhatay MI. Association of estrogen receptor alpha gene polymorphisms with bone mineral density in postmenopausal Indian women. Mol Genet Metab 2006;87:80-7.
21. Govindan S, Ahmad SN, Vedicherla B, Kodati V, Jahan P, Rao KP, et al. Association of progesterone receptor gene polymorphism (PROGINS) with endometriosis, uterine fibroids and breast cancer. Cancer Biomark 2007;3:73-8.
22. Donaldson CJ, Crapanzano JP, Watson JC, Levine EA, Batzer MA. PROGINS Alu insertion and human genomic diversity. Mutat Res 2002;501:137-41.
23. Gohrke SW, Claude JC, Becher H, Kieback DG, Runnebaum IB. Progesterone receptor gene polymorphism is associated with decreased risk for breast cancer by age 50. Cancer Res 2000;60:2348-50.
24. Dluzen DE, Ramírez VD. Progesterone enhances L-dopastimulated dopamine release from the caudate nucleus of freely behaving ovariectomized-estrogen-primed rats. Brain Res 1989;494:122-8.
25. Huang Q, Wang TH, Lu WS, Mu PW, Yang YF, Liang WW, et al. Estrogen receptor alpha gene polymorphism associated with type 2 diabetes mellitus and the serum lipid concentration in Chinese women in Guangzhou. Chin Med J 2006;119:1794-801.
26. Jakimiuk A, Nowicka M, Bogusiewicz M, Adamiak A, Skorupski P, Miotla P, et al. Prevalence of estrogen receptor alpha PvuII and XbaI polymorphism in population of Polish postmenopausal women. Folia Histochem Cytobiol 2007;45:331-8.
27. Low YL, Dunning AM, Dowsett M, Folkerd E, Doody D, Taylor J, et al. Phytoestrogen exposure is associated with circulating sex hormone levels in postmenopausal women and interact with ESR1 and NR1I2 gene variants. Cancer Epidemiol Biomarkers Prev 2007;6:1009-16.